Suzanna C. MacLennan

Suzanna C. MacLennan

Auto-generated profile, based on publicly available information

Suzanna C. MacLennan

Department of Paediatric Neurology Women's and Children's Hospital Adelaide South Australia Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SJSheng Chih Jin
Sheng Chih Jin
SLSara A. Lewis
Sara A. Lewis
SBSomayeh Bakhtiari
Somayeh Bakhtiari
XZXue Zeng
Xue Zeng
MSMichael C. Sierant
Michael C. Sierant
MKMichael C. Kruer
Michael C. Kruer

8 June 2022 in Human Mutation
Verified
Journal Article
Open access
MSMarcello Scala
Marcello Scala
NDNathalie Drouot
Nathalie Drouot
SMSuzanna C. MacLennan
Suzanna C. MacLennan
MWMarja W. Wessels
Marja W. Wessels
MKMagdalena Krygier
Magdalena Krygier
APAmélie Piton
Amélie Piton
Alternative splicing (AS) is crucial for cell‐type‐specific gene transcription and plays a critical role in neuronal differentiation and synaptic plasticity. De novo frameshift variants in NOVA2, encoding a neuron‐specific key splicing factor, have been recently associated with a new neurodevelopmental disorder (NDD) with hypotonia, neurological features, and brain abnormalities. We investigated eight unrelated individuals by exome sequencing (ES) and identified seven novel pathogenic NOVA2 variants, including two with a novel localization at the KH1 and KH3 domains. In addition to a severe NDD phenotype, novel clinical features included psychomotor regression, attention deficit‐hyperactivity disorder (ADHD), dyspraxia, and urogenital and endocrinological manifestations. To test the effect of the variants on splicing regulation, we transfected HeLa cells with wildtype and mutant NOVA2 complementary DNA (cDNA). The novel variants NM_002516.4:c.754_756delCTGinsTT p.(Leu252Phefs*144) and c.1329dup p.(Lys444Glnfs*82) all negatively affected AS events. The distal p.(Lys444Glnfs*82) variant, causing a partial removal of the KH3 domain, had a milder functional effect leading to an intermediate phenotype. Our findings expand the molecular and phenotypic spectrum of NOVA2‐related NDD, supporting the pathogenic role of AS disruption by truncating variants and suggesting that this is a heterogeneous condition with variable clinical course.

11 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
SJSheng Chih Jin
Sheng Chih Jin
SLSara A. Lewis
Sara A. Lewis
SBSomayeh Bakhtiari
Somayeh Bakhtiari
XZXue Zeng
Xue Zeng
MSMichael C. Sierant
Michael C. Sierant
MKMichael C. Kruer
Michael C. Kruer